Implementation
Tagvex in pharmaceuticals.
Tagvex does not replace the İTS data matrix or the EU unique identifier; those codes are printed and reported as usual. The Tagvex number goes on the case and pallet labels of export batches and tender shipments, and onto the pack label where needed. A case scanned at line exit is scanned again at the export warehouse, at loading and when the distributor in the destination country receives it. When a code from a batch is scanned outside the country it was allocated to, a market mismatch detection is opened.
Since early 2010, Türkiye’s Pharmaceutical Track and Trace System (İTS) has serialised medicine packs with a data matrix code, and authorisation holders and other supply chain actors report production, import, sales, returns and dispensing to it. In the EU, Delegated Regulation 2016/161 has required a unique identifier on the outer pack of in-scope medicines since 9 February 2019 (apart from a transition for certain Member States that ended by 9 February 2025 at the latest), and the pharmacist verifies the pack before it reaches the patient. Both systems end at their own market’s border. Once an export batch leaves Türkiye, which distributor and which warehouse it lands in is known only from the manufacturer’s own records.
Request a meeting